General Information
Revision date
2014-03-19
Product name
(R)-Ruxolitinib (>90%)
Chemical name
(R)-Ruxolitinib (>90%)
CAS No.
941678-49-5
1.2.1 Relevant identified uses
To be used only for scientific research and development. Not for use in humans or animals
Icons in SDS
Company Information
company name
Toronto Research Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
orders@trc-canada.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317, H335, H336, H361, H362
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1/2.2 Classification of the Substance or Mixture and Label Elements
Classification according to GHS
According to EU Regulation 1272/2008 and US OSHA 1910.1200) Sensitisation, Skin (Category 1) Specific Target Organ Toxicity, Single Exposure; Respiratory Tract Irritation (Category 3) Specific Target Organ Toxicity, Single Exposure; Central nervous system (Category 3) Reproductive Toxicity (Category 2) Reproductive Toxicity, Effects on or via Lactation (Additional Category) Acute Toxicity, Oral (Category 4)
Hazard statements
Identification (According to EU Regulation 1272/2008 and US OSHA 1910.1200) H317 May cause an allergic skin reaction. H335 May cause respiratory irritation. H336 May cause drowsiness or dizziness. H361 Suspected of damaging fertility or the unborn child. H362 May cause harm to breast-fed children. H302 Harmful if swallowed.
Signal word
Warning
Precautionary statements
P260 Do not breathe dust/fume/gas/mist/vapours/spray P263 Avoid contact during pregnancy/while nursing. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302/P352 IF ON SKIN: Wash with plenty of soap and water P405 Store locked up.
